MIMS drug shortages tracker updated with latest supply issues

All presentations of Champix are currently unavailable and it is not known when they will be back in stock. Resupply of Dalacin cream is expected in early September.

Pharmacists have also reported shortages of loratadine and cetirizine oral solutions. Pinewood have confirmed supply issues with their products until later in June (for loratadine 5mg/5ml oral solution) or July (for cetirizine 1mg/ml oral solution) and GSK Consumer say Piritize Allergy (cetirizine) syrup is out of stock until mid-July. 

The MIMS tracker currently lists a total of 110 products facing supply issues. Other products recently added to the tracker are:

• DHC Continus (dihydrocodeine) 60mg sustained-release tablets - limited supplies until late June
• Ipinnia XL (ropinirole) 8mg tablets - due back in stock in September
• Ventolin (salbutamol) syrup - due back in stock at the end of June
• Xyloproct (lidocaine/hydrocortisone) - resupply expected w/c 19th July

Shortages have now been resolved for Abstral (fentanyl) 800 microgram sublingual tablets, CoAprovel (irbesartan/hydrochlorothiazide), Dermovate (clobetasol) cream, Estradot (estradiol) 75 microgram patches, Diprosalic (betamethasone/salicylic acid) scalp application and Rifinah (rifampicin/isoniazid).

All healthcare professionals have limited free access to the shortages tracker. A MIMS subscription provides unrestricted access to the tracker and the opportunity to receive a weekly shortages bulletin, along with unlimited access to all other MIMS prescribing resources.